Saratov JOURNAL of Medical and Scientific Research

The role of infectious stimulus in the initiation and immune inflammation in psoriasis

Year: 2014, volume 10 Issue: №3 Pages: 530-537
Heading: Skin Diseases Article type: Review
Authors: Slesarenko N.A., Utz S.R., Kulaev K.A., Resnikova M.A., Panina L.V., Popova O.V.
Organization: Saratov State Medical University

Psoriasis is a common skin disease in which the development of the decisive role played by genetic and environmental factors. Many of the candidate genes linked with psoriasis, are directly related to acquired or congenital defects of the immune system, epithelial barrier permeability of the intestinal wall, and the keratinocyte membrain. Formation of an immune response to Th-1 type high expression and activity of antimicrobial peptides like state at their potential infection. This review discusses the possible immune mechanisms are involved in the relationship between infection and disease process in psoriatic skin. We survey the literature and discuss the suitability of infection factors in treatment modality for psoriasis.

1. Kubanova AA, Katunina OP. Immunomorphology and morphogenesis of affected skin foci at psoriasis. Vestn Dermatol Venerol 2010; (1): 70-79
2. Wolf R, Orion Е, Ruocco Е, Ruocco V. Abnormal epidermal barier in the pathogenesis of psoriasis. Clinics in Dermatology 2012; (30): 323-328
3. Kaganova NL, Frigo NV, Kubanov AA, Znamenskaya LE. Genetic aspects of psoriasis (A reviev of literature). Vestn Dermatol Venerol 2009; (4): 20-76
4. Novelli L, Chimenti MS, Chiricozzi A, Perricone R The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies. Autoimmunity Reviews. Jornal; (13): 1-69
5. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007; (25): 606-615
6. Katunina OP, Rezaikina AV Current concepts of skin involvement in immune processes. Vestn Dermatol Venerol 2009; (2): 39-36
7. Tjurin JA, Mustafin IG, Fassahov RC. Prirodnaia ustoycivost bacterie factorsimmune systems, obuslovlennaia proteasami bacteria. Practiche Medicine. Kasan, 2010; 1: 7-13
8. Mansson A, Adrier М, Cardell LQ. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res 2006; (7): 36-7
9. Ryan C, Korman NJ, Gelfand JM, et al. Research gaps in psoriasis: opportunities for future studies. J Acad Dermatol. 2014; 70(1): 1-20
10. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N EnglJ Med 2002; (347): 1151-1160
11. Clarke LE, Helni KF, Hennessy J, Clark JT. Dermal dendritic ctll in psoriasis, dermatitis and normal-appearting skin. J Am Acad Dermatol Volume, 2011; 64 (3): 464-472
12. Macias E, Pereira F, Rietkerk W, Safai B. Superantigens in dermatology. J Am Acad Dermatology 2011; (4): 455-472
13. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; (5): 496-509
14. Zenz R, Eferi R, Kenner L, et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005; (437): 369-375
15. Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005; (11): 43-49
16. Williams ML, Elias PM. From basket weave to barrier. Unifying conctpts for the disorders of cornificftion. Arch Dermatol 1993; (129): 626-629
17. Jablonska S. Pathogenesis and treatment psoriasis. 1981
18. Prinz JO Psoriasis vulgaris — a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Review Clin Exp Dermatol 2001; (6): 326-332
19. Prinz JO Disease mimicry — a phatogenetic conce for T-cell-mediated autoimmune disorders triggered by molecular mimicry? Autoimmun Rev 2004; (3): 10-15
20. Weisenseel P, Prinz JO Incidental detection os S.pyogenes-DNA in psoriatic skin by PCR. Arch Dermatol Res 2005; (296): 573-576
21. Baker BS, Laman JD, PowlesA, et al. Peptidoglycan and Peptidoglycan-specific Th-1 cells in psoriasis lesions. J Pathol 2006; 209: 174-181
22. Elewski B. Does Piturosporum ovale have a role in psoriasis? Arch Dermatol 1990; (126): 1111-1112
23. Waldman A, GilharA, Duck L, et al. Incidence of Candida in psoriasua — a study on the fungal flora о psoriatic patients. Mycoses 1990; 33: 29-32
24. Moles JP, Hadi JC, Guilhou JJ. High prevalenseof an IgG response against murine leukaemia virus (MLV) in patients with psoriasis. Virus Res 2003; (94): 97-101
25. Reich A. Batycka-Baran. New Insights into the Pathogenesis of Psoriasis. European Dermatology 2010; (5: R): 10-15
26. McFadden J, Fry L, Powles AV, Kimber I. Concepts in psoriasis: psoriasis and the extracellular matrix. Brit J Dermatology 2012; (167): 980-986
27. McMilln DL, Richards DG, Mein EA, Nelson CD. Systemic Aspects of Psoriasis: An Integrative Model Based on Intestinal Etiology. Int Med. 1999; (2/3): 105-113
28. Owen CM, Chalmers RJ, O'Sullivan T, Griffiths СЕ. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 2001; (145): 886-90
29. Leung D, Travers J, Giorno RD, et al. Evidence for a Streptococcal Superantigen-driven Process in Acute Guttate Psoriasis. J Clin Invest Inc 1995; 96 (11): 2106-2112
30. Cepicka W, Tielsch R. Focal infections and psoriasis vulgaris. Dermatol Wochenschr 1967; (153): 193-199
31. Ivanov OL, Mareeva EB. Unspeciphic syndroms. Rus J Dedrmatol Venerol 2010; (4): 4-10
32. Valdimarsson Н, Thorleifsdottir RH, Sigurdardottir SL, et al. Psoriasis — as an autoimmune disease caused by molecular mimicry. Trends in immunology 2009; 30 (10): 494-501
33. Grozdev I, Korman N, Tsankov N. Psoriasis as a systemic disease. Clinics in Dermatology 2013; doi: 10.1016/j. clindermatol. 2013.11.001
34. Tlish MM, Sycheva NL, Faustov LA. The clinical and morphological features of cuttate psoriasis. Clin Dermatol Venterol 2012; (5): 65-70
35. England R, Straachan D, Knight TL. Streptococcal tonsillitis and its association with psoriasis: a review. Clinical Otolaryngology & Allied Sciences 1997; (10): 532-535
36. Gudjonsson J, Thorarinsson A, Sigurgeirsson B, Kristinsson K, Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. British Journal of Dermatology 2003; (149): 530-534
37. Sigurdardottir SL, Thorleifsdottir RH, Valdimarsson H, Johnston A. The role palatine tonsils in the pathogenesis and treatment of psoriasis. Brit J of Dermatology. 2013; (168): 337-242
38. Kryukov Al, Tovmasjan AC, Drabkina IV, et al. The role microflore of etyology chronic tonsillitis. Vestn Otholaringol 2010; (3): 4-6
39. Majanski AN. Streptococci: microbyology and patology Woprosy dyagnostig of pediatry 2010; 2 (1): 9-20
40. Rosenberg EW, Patricia WN, Skinner RB. Microorganisms and psoriasis. J National Medical Ass 2009; 86 (4): 305-310
41. Gadjimirsaev GA. О nekotorix pologeniax problem chronic tonsillitis. Vestn Otholaringol 2010; (6): 34-35
42. Bukhova VP, Basanova ЕА, Borodiyk NA. Identificftion of determinant common for polysaccharidts of group A streptococcus, staphylococcus, and epidermal antigen of thymiv epitelium. Rus J Dedrmatol Venerol 1996; (4): 19-21
43. Korotky NG, Peslyak MY. Psoriasis as a consequence of incjrhjration of p-streptococci in the microbiocenosis of highly ptrmeable intestints (a patogenetic concept). Vestn Dermatol Venerol 2005; (5): 9-18
44. Lixoded VG, Uyshuk ND, Jakovlew MYu. Role endotoxine grammotrizatelnix bacteria v infeccionnoi i ne infeccionnoi patologie. Archiv Patology 1996; (2): 8-13
45. Duglas R, Main Е, Mac-Millin D, Nelson К. Systemic aspects of psoriasis: an integrative model based on intestinal etiology. Integrative Medicine 2000 (2): 105-119
46. Pogano Joa. Healing psoriasia: the natural alternative. M., 2001; 270 p Russian (Пегано Д. Лечение псориаза:естественный путь. М., 2001 ;270 с.
47. Mansood Q, ManzoorS, RukhsanaA. Treatment of acute guttate psoriasis with rifampicin. Indian J Dermatol Vcnereol Leprol 2000; (66): 296-8
48. Wilson JK, Sami BS, Al-Suwaidan N, Krowchuk D, Feldman SR. Treatment of Psoriasis in Children: Is There a Role for Antibiotic Therapy and Tonsillectomy? Pediatric Dermatology 2003; (20): 11-15
49. Jager MEA, Jong EM, van de Kerkhof GJ, et al. Efficacy and safety of childhood psoriasis: a systematic literature revive. J Am Acad Dermatol 2010; 62 (6): 1013-1030
50. Mesinkovska N.A., Tomecki K.J.. Novel systemic antibiotics in dermatology. Dermatologic Therapy 2012; (25): 1-5
51. Rosenberg EW, Noah PW, Skinner RB. Treatment of psoriasis with antimicrobial agents. In: Roenigk HH, Maibach HJ, eds. Psoriasis. New York: Marcel Dekker, 1965; p. 505-511
52. Rosenberg EW, Skinner RB, Noah PW. Anti-infectious therapy in psoriasis. In: Psoriasis (Roenigk HH, Maibach HI, eds), 3rd edn. New York: Marcel Dekker, 1998; (1): 373-379
53. Wolff K, Goldsmith LA, Katz SI. Fizpatricks Dermatology in General Medicine. New York, 2012
54. Color Atlas Synopsis of Pediatric Dermatology / Kay Shou-Mei Kane, Peter A. Lio, Alexander J. Stratigos, Richard Allen Johnson. Moskwa, 2011; 488 p.
55. Hoger PH. Kinderdermatologie. Differenzialdiagnostik und Therapie bei kindern und Jugendlichen. M., 2013; 634 s.
56. Cepicka W, Tielsch R. Focal infections and psoriasis vulgaris. Dematol Wochenschr 1967; (153): 193-199
57. Hone SW, Donnelly MJ, Powell F, Blayney AW. Clearance of recalcitrant psoriasis after tonsillectomy. Clin Otolaryngol Allied Sd 1996; (21): 546-547
58. Kataura A, Tsubota H. Clinical analyses of focus tonsil and related diseases in Japan. Acta Otolaryngol Suppl 1996; (523): 161-164
59. Ozawa A, Ohkido M, Haruki Y, et al. Treatmtnts of generalized pustular psoriasis: a multizenter study in Japan. J Dermatol 1999; (26): 141-14
60. Diluvio L, Campione E, Paterno EJ. et al. Childhood nail psoriasis: a useful treatmet with tasarotene 0,05%. Pediatr Dermatol 2007; (24): 332-3
61. Thorleifsdottir RH, Sigurdardottir SL, Sigurgeirsson B, et al. Improvement of psoriasis after tonsillectomy is associated writh a decrease in the frequency of circulating T cells that recognize streptococcal determinants and homologous skin determinants. J Immunol 2012; (188): 5160-5165
62. Malov VA, Рас CG. Aevolucion vzglada na role bacterialnix lipopolisaharidov v patology cheloveka. Vestn RAMN 1997; (8): 33-38
63. Hobejch MM. Heptral in therapy of psoriasis. Vestn Dermatol Venerol 2009; 3: 84-88. Russian (Хобейш M.M. Геп-трал в терапии псориаза. Вестн Дерматол Венерол 2009; (3): 84-88).

2014_03-01_530-537.pdf344.6 KB

No votes yet